TY - JOUR
T1 - Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads
T2 - Technical recommendations
AU - Lencioni, Riccardo
AU - Aliberti, Camillo
AU - De Baere, Thierry
AU - Garcia-Monaco, Ricardo
AU - Narayanan, Govindarajan
AU - O'Grady, Elizabeth
AU - Rilling, William S.
AU - Walker, Duncan
AU - Martin, Robert C.G.
PY - 2014/3/5
Y1 - 2014/3/5
N2 - Transcatheter hepatic arterial administration of irinotecan-loaded drug-eluting beads (DEBIRI) is used to treat liver-only or liver-dominant metastatic disease from colorectal cancer (CRC). Eligibility for DEBIRI should be established in each individual patient by a multidisciplinary team based on comprehensive clinical, imaging, and laboratory assessment. Standardization of DEBIRI technique and protocols would be expected to lead to improved efficacy and safety. The present article provides a set of technical recommendations for the use of DEBIRI in the treatment of hepatic CRC metastases.
AB - Transcatheter hepatic arterial administration of irinotecan-loaded drug-eluting beads (DEBIRI) is used to treat liver-only or liver-dominant metastatic disease from colorectal cancer (CRC). Eligibility for DEBIRI should be established in each individual patient by a multidisciplinary team based on comprehensive clinical, imaging, and laboratory assessment. Standardization of DEBIRI technique and protocols would be expected to lead to improved efficacy and safety. The present article provides a set of technical recommendations for the use of DEBIRI in the treatment of hepatic CRC metastases.
UR - http://www.scopus.com/inward/record.url?scp=84896806046&partnerID=8YFLogxK
U2 - 10.1016/j.jvir.2013.11.027
DO - 10.1016/j.jvir.2013.11.027
M3 - Article
C2 - 24581461
AN - SCOPUS:84896806046
SN - 1051-0443
VL - 25
SP - 365
EP - 369
JO - Journal of Vascular and Interventional Radiology
JF - Journal of Vascular and Interventional Radiology
IS - 3
ER -